CANBERA (dpa-AFX) - SYNLAB AG (SYAB.DE), a medical diagnostic services and
specialty testing firm, said on Tuesday that it has agreed to sell, SYNLAB
SUISSE SA, to Sonic Healthcare Ltd. (SHL.AX), an Australian provider of
laboratory, pathology, and radiology services. The financial terms of the
transaction are not known.

The closing of the deal expected for July 3.

SYNLAB said the sale does not impact its full year 2023 revenue guidance of
around 2.7 billion euros. However, it is projected to have a positive impact on
the adjusted EBITDA margin within the announced full year outlook of 16
percent-18 percent.

SYNLAB was expecting its Swiss operations to post revenues of around 50 million
euros in the second half of the year 2023.



Copyright(c) 2023 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX